DNA-RNA synthesis inhibitor, Gemcitabine HCl, Purity ≥98%

Cat. No.: X24-08-YM084

DNA-RNA synthesis inhibitor, Gemcitabine HCl, Purity ≥98%

Synonym: 122111-03-9; Gemzar; 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; hydrochloride

  • MDL: MFCD01735988
  • CAS Number: 122111-03-9
  • Compound CID: 60749
Product Size
25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Gemcitabine HCl, soluble in DMSO and water and insoluble in ethanol, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting DNA-RNA synthesis. It targets the DNA synthesis (BxPC3 cells), DNA synthesis (Capan2 cells), DNA synthesis (MIAPaCa2 cells), and DNA synthesis (PANC1 cells).
Molecular Weight
299.7
Molecular Formula
C9H11F2N3O4·HCl
Targets
DNA synthesis (BxPC3 cells): 18 nM; DNA synthesis (Capan2 cells): 12 nM; DNA synthesis (MIAPaCa2 cells): 40 nM; DNA synthesis (PANC1 cells): 50 nM
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: insoluble; Water: 18 mg/mL (60.06 mM); Ethanol: insoluble; In vivo: Saline, 18 mg/mL
Applications
Gemcitabine HCl is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of pancreatic cancer, non-small cell lung cancer, and bladder cancer.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0